Skip to main content

Advertisement

SpringerLink
Log in

Complete radiologic and molecular response of HIV-negative primary effusion lymphoma with short-course lenalidomide

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Said J, Cesarman E (2008) Primary effusion lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds) WHO classification of tumours of haematopoietic and lymphoid tissues. IARC, Lyon, pp 260–261

    Google Scholar 

  2. Castillo JJ, Chavez JC, Hernandez-Ilizaliturri FJ, Montes-Moreno S (2015) CD20-negative diffuse large B-cell lymphomas: biology and emerging therapeutic options. Expert Rev Hematol 8(3):343–354

    Article  CAS  PubMed  Google Scholar 

  3. El-Fattah MA (2016) Clinical characteristics and survival outcome of primary effusion lymphoma: a review of 105 patients. Hematol Oncol. doi:10.1002/hon.2372

  4. Chen YB, Rahemtullah A, Hochberg E (2007) Primary effusion lymphoma. Oncologist 12(5):569–576

    Article  PubMed  Google Scholar 

  5. Klein U, Gloghini A, Gaidano G, Chadburn A, Cesarman E, Dalla-Favera R, Carbone A (2003) Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts. Blood 101(10):4115–4121

    Article  CAS  PubMed  Google Scholar 

  6. Shaffer AL, Emre NC, Lamy L, Ngo VN, Wright G, Xiao W, Powell J, Dave S, Yu X, Zhao H, Zeng Y, Chen B, Epstein J, Staudt LM (2008) IRF4 addiction in multiple myeloma. Nature 454(7201):226–231

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Gopalakrishnan R, Matta H, Tolani B, Triche T Jr, Chaudhary PM (2016) Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors. Oncogene 35(14):1797–1810

    Article  CAS  PubMed  Google Scholar 

  8. Zhu YX, Braggio E, Shi CX, Bruins LA, Schmidt JE, Van Wier S, Chang XB, Bjorklund CC, Fonseca R, Bergsagel PL, Orlowski RZ, Stewart AK (2011) Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide. Blood 118(18):4771–4779

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Fink EC, Ebert BL (2015) The novel mechanism of lenalidomide activity. Blood 126(21):2366–2369

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Kwong YL, Pang AW, Leung AY, Chim CS, Tse E (2014) Quantification of circulating Epstein-Barr virus DNA in NK/T-cell lymphoma treated with the SMILE protocol: diagnostic and prognostic significance. Leukemia 28(4):865–870

    Article  CAS  PubMed  Google Scholar 

  11. Antar A, El Hajj H, Jabbour M, Khalifeh I, El-Merhi F, Mahfouz R, Bazarbachi A (2014) Primary effusion lymphoma in an elderly patient effectively treated by lenalidomide: case report and review of literature. Blood Cancer J 4:e190

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors have no acknowledgement to make.

Author information

Authors and Affiliations

  1. Department of Medicine, Professorial Block, Queen Mary Hospital, Pokfulam Road, Hong Kong, Hong Kong

    Thomas S.Y. Chan & Yok-Lam Kwong

  2. Department of Medicine, Princess Margaret Hospital, Kwai Chung, Hong Kong

    Vivien Mak

Authors
  1. Thomas S.Y. Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vivien Mak
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yok-Lam Kwong
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yok-Lam Kwong.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chan, T.S., Mak, V. & Kwong, YL. Complete radiologic and molecular response of HIV-negative primary effusion lymphoma with short-course lenalidomide. Ann Hematol 96, 1211–1213 (2017). https://doi.org/10.1007/s00277-017-2995-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-017-2995-9

Keywords

Search

Navigation